Full-Time
Tooling Technician
Vh-a
Posted on 7/29/2025
Nemera
1,001-5,000 employees
Designs, develops, manufactures drug delivery devices
Compensation Overview
$25 - $40/hr
No H1B Sponsorship
Vernon Hills, IL, USA
In Person
600 darling dr, Vernon Hills, IL 60061, United States
 Mechanical Engineering (1) |
|---|
- High school diploma or equivalent
- 5+ years of experience in mold making, mold design, and/or mold processes strongly preferred
- Ability to lift up to 35 lbs.
- Support and maintain all policies of the company including but not limited to ISO Standards, Health and Safety Requirements, Continuous Improvement, as well as standard work procedures.
- Interact with engineering, production, and tooling staff when troubleshooting molds.
- Identify solutions to complex molding and mold problems as they pertain to injection molding manufacturing.
- Create work orders for service of all molds and maintain records as required.
- Coordinate the implementation of solutions for needed repairs.
- Verify molds are production ready; advise production and engineering of condition of molds.
- Train others on operation of equipment in the Tool Repair department.
- Other duties as assigned.
- Mechanical aptitude.
- Microsoft Office and Engineering software computer skills.
Nemera designs, develops, and manufactures drug delivery devices for pharmaceutical and biotech companies, spanning ophthalmic, nasal, buccal, parenteral, dermal, and inhalation routes. The devices are used to administer medicines and are developed and manufactured in collaboration with customers, often through co-development and customized production in a B2B model. It stands out by offering an end-to-end range of delivery solutions across multiple administration routes, supported by global manufacturing facilities and a wide distribution network. Its goal is to enable safer, more convenient self-administered therapies by providing scalable devices and related design and manufacturing services to partners.
Company Size
1,001-5,000
Company Stage
Acquired
Total Funding
$1.2B
Headquarters
La Verpillière, France
Founded
2014
Simplify's Take
What believers are saying
- Rising demand for diabetes and obesity injection pens drives La Verpillière expansion, starting production 2027.
- New Szczecin hall strengthens leadership in GLP-1 drug market for obesity therapies.
- Milfra acquisition in June 2021 expands footprint in Brazil's gynecology and urology markets.
What critics are saying
- SteadyMed's Releev One captures Symbioze market share in GLP-1 delivery within 12-18 months.
- Ypsomed's dose accuracy wins Novo Nordisk contracts, undercutting La Verpillière capacity in 6-12 months.
- SHL Medical's DAI platform displaces Nemera's devices in Eli Lilly obesity pens within 12-24 months.
What makes Nemera unique
- Nemera specializes in drug delivery devices across ophthalmic, nasal, buccal, parenteral, dermal, and inhalation routes.
- Launched Symbioze wearable injector in October 2021 for self-administration needs.
- Introduced UniSpray unidose nasal system for emergency systemic drug delivery.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Remote Work Options
Company News
Nemera, a global leader in the design, development, and manufacturing of drug delivery device solutions, has inaugurated a new production hall at its state-of-the-art facility in Szczecin, Poland.
That's the new space Nemera has acquired to set up the next state-of-the-art manufacturing facility.
In May of 2014, Rexam sold the plastics business and the Berlin Plant was acquired by Nemera, naming the prescription products business as Centor Inc.
French medical device manufacturer Nemera is expanding its industrial footprint in suburban Chicago.
Nemera France SAS is thrilled to announce the publication of its first integrated ESG report.